Application 040639
- Type
- ANDA
- Sponsor
- VINTAGE PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CARBINOXAMINE MALEATE | CARBINOXAMINE MALEATE | TABLET; ORAL | 4MG | Yes | No |
| 002 | CARBINOXAMINE MALEATE | CARBINOXAMINE MALEATE | TABLET;ORAL | 4MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040639-002 | CARBINOXAMINE MALEATE | CARBINOXAMINE MALEATE | 4MG | TABLET / ORAL | 2008-05-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A040639-002 | CARBINOXAMINE MALEATE | 4MG | TABLET / ORAL | 2008-05-30 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A040639-002 | CARBINOXAMINE MALEATE | 4MG | TABLET / ORAL | 2008-05-30 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A040639-002 | CARBINOXAMINE MALEATE | 4MG | TABLET / ORAL | 2008-05-30 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A040639-002 | CARBINOXAMINE MALEATE | 4MG | TABLET / ORAL | 2008-05-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A040639-002 | AA | 1 | 74a2ff9319b5… |
| 2019-09-15 20:21 UTC | 2019-09 | A040639-002 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A040639-002 | AA | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Karbinal ER | CARBINOXAMINE MALEATE | Aytu Therapeutics, LLC | c40b3f4e-2d71-41a1-a1fc-f64f38724879 | 2026-03-12 | Warnings, Adverse reactions | CARBINOXAMINE MALEATE |
| Carbinoxamine Maleate Extended-Release Oral Suspension | CARBINOXAMINE MALEATE | Neos Therapeutics, LP | 199f46e5-6288-5627-e063-6294a90ae086 | 2026-03-12 | Warnings, Adverse reactions | CARBINOXAMINE MALEATE |
| Carbinoxamine Maleate | CARBINOXAMINE MALEATE | BluCrest Pharmaceuticals, LLC | 163db29b-f035-6696-e063-6294a90a7e06 | 2026-01-06 | Warnings, Adverse reactions | Carbinoxamine Maleate CARBINOXAMINE MALEATE |
| Carbinoxamine Maleate | CARBINOXAMINE MALEATE | Biocomp Pharma, Inc. | 14266e97-674b-b6a9-37a2-a955f0a01c4f | 2025-12-17 | Warnings, Adverse reactions | Carbinoxamine Maleate CARBINOXAMINE MALEATE |
| Carbinoxamine Maleate | CARBINOXAMINE MALEATE | TRIPOINT THERAPEUTICS, LLC | 91ee2e99-082a-4157-b71b-1a7c0e5464fa | 2025-08-05 | Warnings, Adverse reactions | Carbinoxamine Maleate CARBINOXAMINE MALEATE |
| CARBINOXAMINE MALEATE | CARBINOXAMINE MALEATE | Leading Pharma, LLC | 02e13b55-2153-468e-a5bd-57dee062f47f | 2025-07-18 | Warnings, Adverse reactions | CARBINOXAMINE MALEATE CARBINOXAMINE MALEATE |
| Carbinoxamine Maleate | CARBINOXAMINE MALEATE | Genus Lifesciences Inc. | 9d11b197-cfdc-4b9b-9935-2920ccb6e522 | 2024-03-06 | Warnings, Adverse reactions | Carbinoxamine Maleate CARBINOXAMINE MALEATE |
| RyVent | CARBINOXAMINE MALEATE | Carwin Pharmaceutical Associates, LLC | 13ed76c7-49bd-4527-83dc-b4c7d0da9fff | 2024-01-09 | Warnings, Adverse reactions | CARBINOXAMINE MALEATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 64376-605 | Carbinoxamine Maleate | Carbinoxamine Maleate | Par Pharmaceutical | ANDA | Current |
| 64376-605 | Carbinoxamine Maleate | Carbinoxamine Maleate | Par Pharmaceutical | ANDA | Current |
| 64376-605 | Carbinoxamine Maleate | Carbinoxamine Maleate | Par Pharmaceutical, Inc. | ANDA | Current |